Chieko Bannai
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
-
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Heme Oxygenase-1 and Carbon Monoxide 2
-
- Aldose Reductase and Taurine 5
- Co-authors
- Kamejiro Yamashita (16 shared papers)Yukichi Okuda (13 shared papers)Takashi Yamaoka (7 shared papers)Yoichi Tachi (3 shared papers)K. Yamashita (1 shared paper)T Matsushima (1 shared paper)Shiro Bannai (3 shared papers)Mitsuo Itakura (3 shared papers)
- Journals
- Hormone and Metabolic Research (5 papers)Life Sciences (3 papers)Biochemical and Biophysical Research Communications (2 papers)FEBS Letters (1 paper)Diabetes Research and Clinical Practice (1 paper)
- Partner nations
- Japan
In The Last Decade
Chieko Bannai
26 papers receiving 272 citations
Peers
Comparison fields: 5 of 70
- Clinical Biochemistry 87
- Biochemistry 38
- Endocrinology, Diabetes and Metabolism 76
- Physiology 87
- Nephrology 19
Countries citing papers authored by Chieko Bannai
This map shows the geographic impact of Chieko Bannai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chieko Bannai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chieko Bannai more than expected).
Fields of papers citing papers by Chieko Bannai
This network shows the impact of papers produced by Chieko Bannai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chieko Bannai. The network helps show where Chieko Bannai may publish in the future.
Co-authors
The 25 scholars most cited alongside Chieko Bannai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 59 | |
| 2 | 2001 | 35 | |
| 3 | 1991 | 27 | |
| 4 | 1988 | 25 | |
| 5 | 1992 | 24 | |
| 6 | 1998 | 22 | |
| 7 | 1996 | 19 | |
| 8 | 1994 | 11 | |
| 9 | 1999 | 9 | |
| 10 | 1991 | 6 | |
| 11 | Amelioration of dermal lesions in streptozotocin-induced diabetic rats by aminoguanidine. | 1992 | 6 |
| 12 | 1985 | 6 | |
| 13 | 1995 | 5 | |
| 14 | 1986 | 5 | |
| 15 | 1994 | 4 | |
| 16 | Report of a Case of Pancreatic Diabetes with Severe Zinc Deficiency | 1995 | 3 |
| 17 | 1995 | 3 | |
| 18 | 1987 | 3 | |
| 19 | Ascorbic acid prevents the inhibition of DNA synthesis induced by high glucose concentration in cultured human endothelial cells. | 1991 | 3 |
| 20 | 1995 | 2 |
About Chieko Bannai
Chieko Bannai is a scholar working on Molecular Biology, Cell Biology, Physiology, Surgery and Clinical Biochemistry, having authored 26 papers that have together received 284 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (5 papers), Aldose Reductase and Taurine (5 papers), Nitric Oxide and Endothelin Effects (3 papers), Thyroid Disorders and Treatments (2 papers), Pancreatic function and diabetes (2 papers), Sulfur Compounds in Biology (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Pain Management and Treatment (2 papers). The work is most often cited by research in Clinical Biochemistry (87 citations), Biochemistry (38 citations), Endocrinology, Diabetes and Metabolism (76 citations), Physiology (87 citations) and Nephrology (19 citations). Chieko Bannai has collaborated with scholars based in Japan. Frequent co-authors include Kamejiro Yamashita, Yukichi Okuda, Takashi Yamaoka, Yoichi Tachi, K. Yamashita, T Matsushima, Shiro Bannai, Mitsuo Itakura, Masakazu Mizutani and YOSHINOBU KOIDE. Their work appears in journals such as Hormone and Metabolic Research, Life Sciences, Biochemical and Biophysical Research Communications, FEBS Letters and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.